Login / Signup

Bone marrow necrosis and fat embolism syndrome in sickle cell disease during COVID-19 infection treated successfully with sequential red cell and plasma exchange.

Syed RizviMuhammad KhakwaniShivan PanchamDimitris TsitsikasZbigniew RudzkiGhaniah Hassan-SmithMichael BowenChristine WrightDaniel Park
Published in: EJHaem (2022)
Fat embolism syndrome (FES) is a rare life-threatening condition that is particularly seen in milder forms of sickle cell disease (SCD). Widespread systemic fat emboli are generated in the context of extensive bone marrow necrosis. Multi-organ failure with a high morbidity and mortality may quickly develop. Infection with Parvovirus B19 is a common precipitant. Here, the authors report the case of a 35-year-old Afro-Caribbean man with HbSC disease who presented with FES having tested positive for SARS-COV-2. He rapidly became critically ill and required admission to the intensive care unit for organ support. He was treated with red cell exchange and plasma exchange and made a good recovery to leave hospital at week 7.
Keyphrases
  • sickle cell disease
  • bone marrow
  • sars cov
  • adipose tissue
  • single cell
  • mesenchymal stem cells
  • emergency department
  • healthcare
  • fatty acid
  • case report
  • clinical trial
  • stem cells